The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study

Author:

Brink Vera12ORCID,Andleeb Humma2,Gayer-Anderson Charlotte34ORCID,Arango Celso5,Arrojo Manuel6,Berardi Domenico7,Bernardo Miquel891011ORCID,Bobes Julio12,Del-Ben Cristina Marta13,Ferraro Laura14ORCID,de Haan Lieuwe15,La Barbera Daniele14,La Cascia Caterina14,Lasalvia Antonio16ORCID,Llorca Pierre-Michel171819,Menezes Paolo Rossi2021,Pignon Baptiste1722ORCID,Sanjuán Julio23,Santos José Luis24,Selten Jean-Paul25,Tarricone Ilaria26,Tortelli Andrea2728,Tripoli Giada1429,Velthorst Eva30ORCID,Rutten Bart P F25,van Os Jim252931ORCID,Quattrone Diego143233,Murray Robin M2932,Jones Peter B3435ORCID,Morgan Craig34,Di Forti Marta3233,Jongsma Hannah E136,Kirkbride James B234ORCID

Affiliation:

1. Department of Psychosis, University Center Psychiatry, University Medical Center Groningen, University of Groningen , Groningen , The Netherlands

2. PsyLife Group, Division of Psychiatry, University College London , London , UK

3. ESRC Centre for Society and Mental Health, King’s College London , London , UK

4. Institute of Psychiatry, Psychology and Neuroscience, King’s College London Department of Health Service and Population Research, , London , UK

5. Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM Department of Child and Adolescent Psychiatry, , Madrid , Spain

6. Department of Mental Health and Drug-Addiction Assistance, Health Service of Galicia, Psychiatric Genetic Group IDIS, Hospital Clínico Universitario de Santiago de Compostela, affiliated center to Centro de Investigación Biomédica en Red de Salud Mental, Servicio Gallego de Salud , Santiago de Compostela , Spain

7. Alma Mater Studiorium Università di Bologna , Bologna , Italy

8. Barcelona Clinic Schizophrenia Unit, Hospital Clinic de Barcelona , Barcelona , Spain

9. Departament de Medicina, Institut de Neurociències (UBNeuro), Universitat de Barcelona (UB) , Barcelona , Spain

10. Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS) , Barcelona , Spain

11. CIBERSAM, ISCIII , Barcelona , Spain

12. Department of Medicine, Psychiatry Area, School of Medicine, Universidad de Oviedo, Centro de Investigación Biomédica en Red de Salud Mental , Oviedo , Spain

13. Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo , São Paulo , Brazil

14. Department of Biomedicine, Neuroscience, and Advanced Diagnostics, Section of Psychiatry, University of Palermo , Palermo , Italy

15. Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam , Amsterdam , The Netherlands

16. Department of Neuroscience, Biomedicine and Movement, Section of Psychiatry, University of Verona , Verona , Italy

17. Fondation FondaMental , Créteil , France

18. CMP B CHU , Clermont-Ferrand , France

19. Université Clermont Auvergne , Clermont-Ferrand , France

20. Faculdade de Medicina, Universidade de São Paulo Department of Preventive Medicine, , São Paulo , Brazil

21. Núcleo de Pesquina em Saúde Mental Populacional, Universidade de São Paulo , São Paulo , Brazil

22. Université Paris-Est-Créteil (UPEC) and AP-HP, Hôpitaux Universitaires « H. Mondor », DMU IMPACT, Psychiatry department and INSERM, IMRB, Translational Neuropsychiatry , Créteil , France

23. Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental , Valencia , Spain

24. Department of Psychiatry, Servicio de Psiquiatría Hospital “Virgen de la Luz” , Cuenca , Spain

25. Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre , Maastricht , The Netherlands

26. Psychiatry Unit, Alma Mater Studiorium Università di Bologna Department of Medical and Surgical Science, , Bologna , Italy

27. Institut National de la Santé et de la Recherche Médicale, U955 , Créteil , France

28. Pôle Psychiatrie Précarité, Groupe Hospitalier Paris Psychiatrie Neurosciences , Paris , France

29. Institute of Psychiatry, Psychology and Neuroscience, King’s College London Department of Psychosis Studies, , London , UK

30. Department of Research, Mental Health Organization “GGZ Noord-Holland-Noord” , Heerhugowaard , The Netherlands

31. Brain Center, University Medical Center Utrecht , Utrecht , The Netherlands

32. National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London , London , UK

33. Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London , London , UK

34. Department of Psychiatry, University of Cambridge, Herchel Smith Building for Brain & Mind Sciences , Cambridge , UK

35. CAMEO Early Intervention Service, Cambridgeshire and Peterborough National Health Service Foundation Trust, Chesterton Medical Centre , Cambridge , UK

36. Veldzicht Centre for Transcultural Psychiatry , Balkbrug , The Netherlands

Abstract

Abstract Background and Hypothesis Recent findings suggest the incidence of first-episode psychotic disorders (FEP) varies according to setting-level deprivation and cannabis use, but these factors have not been investigated together. We hypothesized deprivation would be more strongly associated with variation in FEP incidence than the prevalence of daily or high-potency cannabis use between settings. Study Design We used incidence data in people aged 18–64 years from 14 settings of the EU-GEI study. We estimated the prevalence of daily and high-potency cannabis use in controls as a proxy for usage in the population at-risk; multiple imputations by chained equations and poststratification weighting handled missing data and control representativeness, respectively. We modeled FEP incidence in random intercepts negative binomial regression models to investigate associations with the prevalence of cannabis use in controls, unemployment, and owner-occupancy in each setting, controlling for population density, age, sex, and migrant/ethnic group. Study Results Lower owner-occupancy was independently associated with increased FEP (adjusted incidence rate ratio [aIRR]: 0.76, 95% CI: 0.61–0.95) and non-affective psychosis incidence (aIRR: 0.68, 95% CI: 0.55–0.83), after multivariable adjustment. Prevalence of daily cannabis use in controls was associated with the incidence of affective psychoses (aIRR: 1.53, 95% CI: 1.02–2.31). We found no association between FEP incidence and unemployment or high-potency cannabis use prevalence. Sensitivity analyses supported these findings. Conclusions Lower setting-level owner-occupancy and increased prevalence of daily cannabis use in controls independently contributed to setting-level variance in the incidence of different psychotic disorders. Public health interventions that reduce exposure to these harmful environmental factors could lower the population-level burden of psychotic disorders.

Funder

European Community’s Seventh Framework Program

São Paulo Research Foundation

University Medical Centre Groningen

NIHR UCLH BRC

Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III

European Union

European Commission

European Union—NextGenerationEU

CIBERSAM

Madrid Regional Government

European Union Structural Funds

European Union Seventh Framework Program

European Union H2020 Program

Innovative Medicines Initiative 2 Joint Undertaking: Project PRISM-2

Project AIMS-2-TRIALS

Horizon Europe

National Institute of Mental Health of the National Institutes of Health

Fundación Familia Alonso

Fundación Alicia Koplowitz

Publisher

Oxford University Press (OUP)

Reference46 articles.

1. A systematic review and meta-analysis of the incidence of psychotic disorders: the distribution of rates and the influence of gender, urbanicity, immigration and socio-economic level;Castillejos;Psychol Med.,2018

2. Treated incidence of psychotic disorders in the multinational EU-GEI study;Jongsma;JAMA Psychiatry.,2018

3. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology;McGrath;BMC Med.,2004

4. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization Ten-Country study;Jablensky;Psychol Med Monogr Suppl.,1992

5. The incidence of non-affective psychotic disorders in low- and middle-income countries: a systematic review and meta-analysis;John-Baptiste Bastien;Soc Psychiatry Psychiatr Epidemiol.,2023

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3